⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7524063 | 0.80 | FFAR2 (0.37) | — | |
| SCHEMBL10049702 | 0.78 | — | — | |
| SCHEMBL28026324 | 0.78 | — | — | |
| SCHEMBL28026323 | 0.78 | — | — | |
| SCHEMBL28026350 | 0.78 | — | — | |
| SCHEMBL7412590 | 0.72 | — | — | |
| SCHEMBL7349104 | 0.70 | — | — | |
| SCHEMBL2846695 | 0.70 | — | — | |
| SCHEMBL11308102 | 0.70 | HPGD (0.32) | — | |
| SCHEMBL3896923 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777190-B1 | Crosstalk inhibitors and their uses | BIOSITE, INC. | 2004-08-17 | — | — | US | disclosed |
| EP-0585310-B1 | CROSSTALK INHIBITORS AND THEIR USES | BIOSITE DIAGNOSTICS INC (US) | 1999-03-17 | — | — | EP | disclosed |
| US-5525524-A | ASSAY FOR DETERMINING AMOUNT OR PRESENCE OF A TARGET HAPTEN WHICH COMPETES (FOR BINDING TO ITS SPECIFIC RECEPTOR) WITH AT LEAST ONE ANALOGUE ON A CONJUGATE IN A REACTION MIXTURE | BIOSITE DIAGNOSTICS, INC. (US) | 1996-06-11 | — | — | US | disclosed |
| WO-1992018868-A1 | CROSSTALK INHIBITORS AND THEIR USES | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1992-10-29 | — | — | WO | disclosed |